- Report
- October 2023
- 181 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- August 2023
- 150 Pages
Global
From €4077EUR$4,250USD£3,502GBP
- Report
- February 2024
- 175 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Report
- October 2023
- 166 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Report
- February 2024
- 119 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- February 2024
- 115 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- February 2024
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- February 2024
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- August 2023
- 117 Pages
Global
From €4317EUR$4,500USD£3,708GBP
- Report
- August 2023
- 120 Pages
Global
From €4317EUR$4,500USD£3,708GBP
- Report
- March 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- March 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- January 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- January 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- October 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,596GBP
- Report
- October 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,596GBP
- Report
- September 2023
- 50 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Report
- November 2023
- 107 Pages
Global
From €3500EUR$3,908USD£3,112GBP
The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more